Results 91 to 100 of about 4,200 (201)

Identifying treatment response to antihypertensives in patients with obesity-related hypertension

Clinical Hypertension, 2017
Background In patients with obesity-related hypertension (ORH), reaction to antihypertensive medication is likely influenced by patientcharacteristics.
Ilse M. Schrover, Jannick A. N. Dorresteijn, Jodine E. Smits, A. H. Jan Danser, Frank L. J. Visseren, Wilko Spiering   +5 more
doaj   +1 more source

Direct renin inhibitor aliskiren in women with menopausal metabolic syndrome and arterial hypertension

Кардиоваскулярная терапия и профилактика, 2011
Aim. To study the effectiveness of a direct renin inhibitor, aliskiren, in patients with menopausal metabolic syndrome (MMS), and to assess aliskiren effects on blood pressure (BP), carbohydrate and lipid metabolism parameters, microalbuminuria, and ...
Yu. V. Zhernakova, V. B. Mychka, Yu. A. Ponomarev, S. N. Tolstov, E. V. Tishina, K. P. Ivanov, I. E. Chazova   +6 more
doaj   +1 more source

Renin-angiotensin-aldosterone system in the elderly: rational use of aliskiren in managing hypertension

Clinical Interventions in Aging, 2009
Karl AndersenDepartment of Medicine, Division of Cardiology, Landspitali University Hospital, University of Iceland, Reykjavik, IcelandAbstract: The overall purpose of hypertension treatment is 2-fold. First, patients often have symptoms that are related
Karl Andersen
doaj  

Representative capillary images of wildtype (WT) Sprague–Dawley rats (A), non-diabetic (NDM) Ren2 rats (B), and diabetic (DM) Ren2 rats treated with vehicle (C), aliskiren (D) or aliskiren+HRP (E).

, 2014
Diabetic Ren2 rat retinas showed further increased acellular capillaries (arrow) and both aliskiren and aliskiren+HRP reduced this.
Yunyang Wang (589235), Qiuhong Li (230299), A. H. Jan Danser (210757), Wendy W. Batenburg (589233), Mieke van den Heuvel (589236), Richard van Veghel (210733), Amrisha Verma (589234), Ping Zhu (11521)   +7 more
core   +1 more source

Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension

, 2008
INTRODUCTION: Aliskiren is the first in a new class of direct renin inhibitors to be approved for the treatment of hypertension.Patients and methods. In this double-blind, multicentre trial, 694 patients with hypertension (mean sitting diastolic blood ...
Keefe, D.L., Yu, C.M., Bheda, M., Ford, J., Dietz, R., Prescott, M.F., Dechend, R.   +6 more
core   +1 more source

Aliskiren suppresses the renin–angiotensin–aldosterone system and reduces blood pressure and albuminuria in elderly chronic kidney disease patients with hypertension

, 2012
Yoshiyuki Morishita,1 Toshihiro Yasui,2 Akihiko Numata,1 Akira Onishi,1 Kenichi Ishibashi,3 Eiji Kusano11Department of Internal Medicine, Jichi Medical University, Shimotsuke, Japan; 2National Health Insurance Yukawa Clinic, Niimi, Japan; 3Department of ...
Onishi A, Kusano E, Morishita Y, Yasui T, Numata A, Ishibashi K   +5 more
core  

Aliskiren reduces the peritoneal fibrosis in vivo after chronic peritoneal dialysis.

, 2013
The groups of animals were the same as in Fig. 3. At the end of the 4 week-dialysis period, peritoneal mesothelial cells (PMCs) were isolated and the fibronectin (a) and collagen III (b) mRNA levels were determined in PMCs and normalized to the β-actin ...
Jesús Masiá (324788), Esther Simarro (324792), Juan Pérez-Martínez (324784), Valentín Ceña (218864), Agustín Ortega (324790), Francisco C. Pérez-Martínez (324785), Blanca Carrión (324786), Syong H. Nam-Cha (324794)   +7 more
core   +1 more source

Representative retinal micrographs of wildtype (WT) Sprague–Dawley rats, non-diabetic (NDM) Ren2 rats, and diabetic (DM) Ren2 rats treated with vehicle, aliskiren or aliskiren+HRP (A).

, 2014
INL: inner nuclear layer; IPL: inner plexiform layer; RGC: retinal ganglion cell layer. Quantitative measurement of cell density in RGC layer in the central (B) and peripheral (C) retinas of wildtype (WT) Sprague–Dawley rats, non-diabetic (NDM) Ren2 rats,
Yunyang Wang (589235), Qiuhong Li (230299), A. H. Jan Danser (210757), Wendy W. Batenburg (589233), Mieke van den Heuvel (589236), Richard van Veghel (210733), Amrisha Verma (589234), Ping Zhu (11521)   +7 more
core   +1 more source

Clinical application of direct renin inhibitor aliskiren in combined therapy of patients with arterial hypertension and metabolic syndrome

RUDN Journal of Medicine, 2010
The article presents the results of clinical application of direct renin inhibitor aliskiren in combination therapy in patients with arterial hypertension and obesity.
O V Dralova, M L Maximov, A S Ermolaeva
doaj  

The Anti-Inflammatory Effect of Different Doses of Aliskiren in Rat Models of Inflammation

Drug Design, Development and Therapy, 2020
Tavga Ahmed Aziz, Ahmed Azad Kareem, Hemn Hassan Othman, Zheen Aorahman Ahmed Department of Pharmacology and Toxicology, College of Pharmacy, University of Sulaimani, Sulaimani, Kurdistan Region, IraqCorrespondence: Tavga Ahmed AzizDepartment of ...
Aziz TA, Kareem AA, Othman HH, Ahmed ZA
doaj